Publications
18
Citations
570
Est. group size
—
Recurring co-author estimate
Active years
39
Publishing since 1987
The available bibliographic record for Kathleen A. Rogers is very limited, showing only two recent publications related to a multicenter clinical trial testing venetoclax combined with R-CHOP chemotherapy for Richter Syndrome, a rare and aggressive complication of chronic lymphocytic leukemia. The OpenAlex topic listings (relating to parasitic diseases) appear to be mismatched with this researcher's actual work and are not reflected in the visible publications. Based on this limited data, definitive conclusions about a sustained research program cannot be drawn.
The publication record over the last decade shows minimal and sporadic output, with only one publication in 2023 and one in 2025, and no publications recorded in the other years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- 73 | PRIMARY ENDPOINT EVALUATION OF A MULTICENTER PHASE 2 STUDY OF VENETOCLAX IN COMBINATION WITH R‐CHOP (VR‐CHOP) FOR PATIENTS WITH RICHTER SYNDROME
Hematological Oncology · 2025
- Initial results of a multicenter phase 2 study of venetoclax in combination with R‐CHOP (VR‐CHOP) for patients with Richter Syndrome
Hematological Oncology · 2023
- Hematological Oncology×2
- Dawn M. Wetzel
Medicine · Purdue University West Lafayette
- Bradford S. McGwire
Medicine · The Ohio State University
- Abhay R. Satoskar
Medicine · The Ohio State University
- Christine A. Petersen
Medicine · The Ohio State University
- Fabiano Borges Figueiredo
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile